The EDGE

Hyperglycemia as a possible risk factor for mold infections—the potential preventative role of intensified glucose control in allogeneic hematopoietic stem cell transplantation

S Fuji, J Löffler, B N Savani, H Einsele and M Kapp

Bone Marrow Transplant 2017 52: 657-662; advance online publication, December 12, 2016; 10.1038/bmt.2016.306

Prevention and treatment of bone loss and fractures in patients undergoing a hematopoietic stem cell transplant: a systematic review and meta-analysis

X Pundole, H I Cheema, G S Petitto, M A Lopez-Olivo, M E Suarez-Almazor and H Lu

Bone Marrow Transplant 2017 52: 663-670; advance online publication, January 23, 2017; 10.1038/bmt.2016.312

Original Articles

ACUTE LEUKEMIA

Latin America: the next region for haematopoietic transplant progress

G Jaimovich, J Martinez Rolon, H Baldomero, M Rivas, I Hanesman, L Bouzas, C Bonfim, J Palma, A Kardus-Urueta, D Ubidia, W Bujan-Boza, O Gonzalez-Ramella, G Ruiz-Argüelles, D Gomez-Almaguer, G Espino, E Fanilla, D Gonzalez, A Carrasco, S Galeano, G Borelli, M Hernandez-Gimenez, M Pasquini, Y Kodera, A Gratwohl, M Gratwohl, J Nuñez, J Szer, R P Gale, D Niederwieser and A Seber

Bone Marrow Transplant 2017 52: 671-677; advance online publication, January 23, 2017; 10.1038/bmt.2016.361

Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

C Roux, K Tifratene, G Socié, C Galambrun, Y Bertrand, F Rialland, C Jubert, C Pochon, C Paillard, A Sirvent, B Nelken, J P Vannier, C Freycon, Y Beguin, N Raus, I Yakoub-Agha, M Mohty, J-H Dalle, G Michel, C Pradier, R Peffault de Latour and P-S Rohrlich

Bone Marrow Transplant 2017 52: 678-682; advance online publication, January 23, 2017; 10.1038/bmt.2016.360

LYMPHOMA

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma

L Castagna, S Bramanti, R Devillier, B Sarina, R Crocchiolo, S Furst, J El-Cheikh, A Granata, C Faucher, S Harbi, L Morabito, J Mariotti, S Puvinathan, P J Weiller, C Chabannon, D Mokart, C Carlo-Stella, R Bouabdallah, A Santoro and D Blaise

Bone Marrow Transplant 2017 52: 683-688; advance online publication, January 16, 2017; 10.1038/bmt.2016.348

Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy

J Gauthier, L Castagna, F Garnier, T Guillaume, G Socié, S Maury, N Maillard, R Tabrizi, T Marchand, J Malfuson, A Gac, E Gyan, M Mercier, Y Béguin, J Delage, P Turlure, A Marçais, S Nguyen, R Dulery, J Bay, A Huynh, E Daguindau, J Cornillon, C Régny, M Michallet, R Peffault de Latour, I Yakoub-Agha and D Blaise

Bone Marrow Transplant 2017 52: 689-696; advance online publication, January 9, 2017; 10.1038/bmt.2016.349

Improving outcomes after allogeneic hematopoietic cell transplantation for Hodgkin lymphoma in the brentuximab vedotin era

L Hegerova, Q Cao, A Lazaryan, B L McClune, D J Weisdorf, C G Brunstein and V Bachanova

Bone Marrow Transplant 2017 52: 697-703; advance online publication, January 30, 2017; 10.1038/bmt.2016.357

APLASTIC ANEMIA

Cotransplantation of bone marrow-derived mesenchymal stem cells in haploidentical hematopoietic stem cell transplantation in patients with severe aplastic anemia: an interim summary for a multicenter phase II trial results

Z Liu, Y Zhang, H Xiao, Z Yao, H Zhang, Q Liu, B Wu, D Nie, Y Li, Y Pang, Z Fan, L Li, Z Jiang, F Duan, H Li, P Zhang, Y Gao, L Ouyang, C Yue, M Xie, C Shi, Y Xiao and S Wang

Bone Marrow Transplant 2017 52: 704-710; advance online publication, January 9, 2017; 10.1038/bmt.2016.347

SOLID CANCERS

Skeletal outcome in long-term survivors of childhood high-risk neuroblastoma treated with high-dose therapy and autologous stem cell rescue

P Utriainen, A Vatanen, S Toiviainen-Salo, U Saarinen-Pihkala, O Mäkitie and K Jahnukainen

Bone Marrow Transplant 2017 52: 711-716; advance online publication, January 9, 2017; 10.1038/bmt.2016.345

GRAFT MANIPULATION

Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants

B E Shaw, N P Mayor, R M Szydlo, W P Bultitude, C Anthias, K Kirkland, J Perry, A Clark, S Mackinnon, D I Marks, A Pagliuca, M N Potter, N H Russell, K Thomson, J A Madrigal and S G E Marsh

Bone Marrow Transplant 2017 52: 717-725; advance online publication, January 16, 2017; 10.1038/bmt.2016.352

CONDITIONING

Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature

K Mallhi, P J Orchard, W P Miller, Q Cao, J Tolar and T C Lund

Bone Marrow Transplant 2017 52: 726-732; advance online publication, January 16, 2017; 10.1038/bmt.2016.356

TRANSPLANT TOXICITIES

Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants

I G Glezerman, S Devlin, M Maloy, M Bui, E A Jaimes, S A Giralt and A A Jakubowski

Bone Marrow Transplant 2017 52: 733-738; advance online publication, January 16, 2017; 10.1038/bmt.2016.343

Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantation

M Berro, M V Palau Nagore, M M Rivas, P Longo, C Foncuberta, A Vitriú, G Remaggi, J Martínez Rolon, G Jaimovich, A Requejo, L Feldman, K Padros, M B Rodríguez, B E Shaw, I Larripa, C B Belli and G D Kusminsky

Bone Marrow Transplant 2017 52: 739-744; advance online publication, January 30, 2017; 10.1038/bmt.2016.355

GRAFT-VERSUS-HOST DISEASE

A high migratory capacity of donor T-cells in response to the lymph node homing receptor CCR7 increases the incidence and severity of GvHD

I Portero-Sainz, V Gómez-García de Soria, C Cuesta-Mateos, C Fernández-Arandojo, L Vega-Piris, M Royg, B Colom-Fernández, A Marcos-Jiménez, B Somovilla-Crespo, A Ramírez-Mengíbar, V López-Huete, A de Rosendo-Serrano, A Kreutzman and C Muñoz-Calleja

Bone Marrow Transplant 2017 52: 745-752; advance online publication, January 23, 2017; 10.1038/bmt.2016.342

QOL AND PATIENTS' CARE

Investigating the temporal course, relevance and risk factors of fatigue over 5 years: a prospective study among patients receiving allogeneic HSCT

P Esser, K Kuba, A Mehnert, A Schwinn, L Schirmer, F Schulz-Kindermann, M Kruse, U Koch, A R Zander, N Kröger, G Schilling, H Götze and A Scherwath

Bone Marrow Transplant 2017 52: 753-758; advance online publication, January 23, 2017; 10.1038/bmt.2016.344

Letters to the Editor

Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic hematopoietic stem cell transplantation

E McDuffee, G Aue, L Cook, C Ramos-Delgado, R Shalabi, T Worthy, P Vo and R W Childs

Bone Marrow Transplant 2017 52: 759-761; advance online publication, January 9, 2017; 10.1038/bmt.2016.346

Use of defibrotide to treat transplant-associated thrombotic microangiopathy: a retrospective study of the Paediatric Diseases and Inborn Errors Working Parties of the European Society of Blood and Marrow Transplantation

L Yeates, M A Slatter, S Bonanomi, F L W I Lim, S Y Ong, A Dalissier, W Barberi, A Shulz, M Duval, C Heilmann, A Willekens, W H Y Hwang, C Uderzo, P Bader and A R Gennery

Bone Marrow Transplant 2017 52: 762-764; advance online publication, January 16, 2017; 10.1038/bmt.2016.351

Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibroblasts

C Sorge, L Pereboeva, E Westin, W T Harris, D R Kelly and F Goldman

Bone Marrow Transplant 2017 52: 765-768; advance online publication, January 16, 2017; 10.1038/bmt.2016.353

Single institution experience with G-CSF mobilized T-cell replete haploidentical hematopoietic cell transplantation

E Huselton, M Slade, J F DiPersio, P Westervelt, R Vij, G L Uy, T A Fehniger, C N Abboud, F Gao, M A Schroeder and R Romee

Bone Marrow Transplant 2017 52: 769-771; advance online publication, January 9, 2017; 10.1038/bmt.2016.354

Is day +1 omission of methotrexate associated with higher incidence of acute GvHD in hematopoietic stem cell transplantation?

E Leon-Rodriguez, M M Rivera-Franco and A Campos-Castro

Bone Marrow Transplant 2017 52: 772-774; advance online publication, January 23, 2017; 10.1038/bmt.2016.359

Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes

P D E Miller, T I de Silva, R Skinner, M Gilleece, A Peniket, A Hamblin, D Greenfield, C Anthias, K Peggs, A Madrigal and J A Snowden on behalf of the BSBMT Clinical Trials Committee

Bone Marrow Transplant 2017 52: 775-777; advance online publication, January 23, 2017; 10.1038/bmt.2016.362

MALDI-TOF MS in post-transplant bloodstream infections: reliable identification of causative bacteria in the neutropenic phase

M Kanaya, Y Hayashi, D Hashimoto, T Endo, J Sugita, H Ohigashi, J Hashiguchi, T Matsukawa, S Matsuoka, M Kosugi-Kanaya, H Goto, M Onozawa, K Kahata, K Fujimoto, T Kondo, K Akizawa, H Shibuya, C Shimizu and T Teshima

Bone Marrow Transplant 2017 52: 778-780; advance online publication, January 30, 2017; 10.1038/bmt.2016.365

Significant nutrient deposition in the liver after allogeneic hematopoietic stem cell transplantation: pathological analysis of 25 autopsy cases

S Fuji, A M Maeshima, S-W Kim and T Fukuda

Bone Marrow Transplant 2017 52: 781-782; advance online publication, January 23, 2017; 10.1038/bmt.2016.367

Additional infusions of mesenchymal stem cells improve response rate in multidrug-resistant GvHD patients

M Cetin, G Akyol, Z B Gonen, M Keklik, G Zararsiz, A Unal, N L Tiren-Verbeet and L Kaynar

Bone Marrow Transplant 2017 52: 783-785; advance online publication, March 13, 2017; 10.1038/bmt.2017.1

Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AML

V Blum, A D Heini, U Novak, B M Taleghani, G M Baerlocher, K Leibundgut, K Seipel, Y Banz, M Bargetzi and T Pabst

Bone Marrow Transplant 2017 52: 786-788; advance online publication, February 13, 2017; 10.1038/bmt.2017.2

Increased incidence of oral and gastrointestinal secondary cancer after allogeneic hematopoietic stem cell transplantation

Y Tanaka, S Kurosawa, K Tajima, T Tanaka, R Ito, Y Inoue, K Okinaka, Y Inamoto, S Fuji, S-W Kim, R Tanosaki, T Yamashita and T Fukuda

Bone Marrow Transplant 2017 52: 789-791; advance online publication, February 13, 2017; 10.1038/bmt.2017.4

Fertility preservation in an adolescent boy: inducing puberty and spermatogenesis prior to elective, non-urgent bone marrow transplantation

C Ho and M Zacharin

Bone Marrow Transplant 2017 52: 792-793; advance online publication, March 13, 2017; 10.1038/bmt.2017.6

Effective desensitization of donor-specific HLA antibodies using platelet transfusion bearing targeted HLA in a case of HLA-mismatched allogeneic stem cell transplantation

T Yamashita, K Ikegame, H Kojima, H Tanaka, K Kaida, T Inoue and H Ogawa

Bone Marrow Transplant 2017 52: 794-796; advance online publication, February 6, 2017; 10.1038/bmt.2017.10

Corrigenda

Haploidentical transplantation with post-infusion cyclophosphamide in advanced Hodgkin lymphoma

Bone Marrow Transplant 2017 52: 797; 10.1038/bmt.2017.26

Latin America: the next region for haematopoietic transplant progress

Bone Marrow Transplant 2017 52: 798; 10.1038/bmt.2017.48